|
|
|
Netira
Topical treatment of external infections of the eye and
its adnexa caused by germs sensitive to netilmicin,
including germs producing adenylating
and phosphorylating enzymes
Adults
Due to its characteristics, Netira
first-choice antibiotic for the treatment
all eye infections:
• bacterial conjunctivitis and blepharitis
• bacterial keratitis
• corneal ulcer
Children
Due to its safety and tolerability, Netira
is the best choice for the treatment of
eye infections in children, even from
first weeks of life:
• dachryocistitis and conjunctivitis
Surgery
Due to its wide spectrum and low resistance
induction, Netira is effective in
the prophylaxis of surgical infections:
• before and after cataract surgery
Safety of use
Netira did not show any cytotoxicity potential on conjunctival and corneal
cells; whereas ofloxacin, which causes dose-depending toxicity, drastically
reduces cell proliferation and vitality with high significance indexes.
* No cytotoxic effects on the corneal epithelium in animal
* No cytotoxic effects on the human conjunctival and corneal epithelium
NetiraTM is the first-choice treatment for external
eye infections
• Fast bactericide action
• Wide spectrum of action
• Low resistance induction
• Long lasting PAE effects
• Long permanence in tear film at effective concentrations
• Strong antibacterial activity
• Very good clinical efficacy in ocular infections
at adults and children
• Good safety with no cytotoxic effects
• Highly tolerable in children as well
• Effective in preoperative and postoperative prophylaxis
|
|
|
| |
|
|
|
|
